Advertisement

 

 

Text Messaging for Improving Antiretroviral Therapy Adherence: No Effects After 1 Year in a Randomized Controlled Trial Among Adolescents and Young Adults.

Text Messaging for Improving Antiretroviral Therapy Adherence: No Effects After 1 Year in a Randomized Controlled Trial Among Adolescents and Young Adults.
Author Information (click to view)

Linnemayr S, Huang H, Luoto J, Kambugu A, Thirumurthy H, Haberer J, Wagner G, Mukasa B,


Linnemayr S, Huang H, Luoto J, Kambugu A, Thirumurthy H, Haberer J, Wagner G, Mukasa B, (click to view)

Linnemayr S, Huang H, Luoto J, Kambugu A, Thirumurthy H, Haberer J, Wagner G, Mukasa B,

Advertisement
Share on FacebookTweet about this on TwitterShare on LinkedIn

American journal of public health 2017 10 19() e1-e7 doi 10.2105/AJPH.2017.304089

Abstract
OBJECTIVES
To assess the effectiveness of Short Message Service (SMS) reminder messages on antiretroviral and cotrimoxazole prophylaxis adherence among HIV-positive youths as well as the relative effectiveness of SMS with and without a response option.

METHODS
Eligible HIV-positive patients aged 15 to 22 years at 2 HIV clinics in Kampala, Uganda, participated in a year-long parallel individual-randomized controlled trial and were assigned in a 1-to-1-to-1 ratio to a weekly SMS message group, weekly SMS message with response option group, or a usual-care control group.

RESULTS
We enrolled 332 participants. Electronically measured mean adherence was 67% in the control group, 64% in the 1-way SMS group (95% confidence interval [CI] = 0.77, 1.14), and 61% in the 2-way SMS group (95% CI = 0.75, 1.12) in an intent-to-treat analysis. Results for secondary outcomes and complete-case analysis were similarly statistically insignificant across groups.

CONCLUSIONS
Despite previous evidence that interventions using SMS reminders can promote antiretroviral therapy adherence, this study shows that they are not always effective in achieving behavior change. More research is needed to find out for whom, and under what conditions, they can be beneficial.

TRIAL REGISTRATION
ClinicalTrials.gov identifier: NCT00830622. (Am J Public Health. Published online ahead of print October 19, 2017: e1-e7. doi:10.2105/AJPH.2017.304089).

Submit a Comment

Your email address will not be published. Required fields are marked *

four × five =

[ HIDE/SHOW ]